Schizophrenia

Definition | Aetiology | Risk Factors | Clinical Presentation | Investigations | Management | When to Refer | References

Definition

Schizophrenia is a chronic and severe mental health disorder characterised by disturbances in thought, perception, emotion, and behaviour. The condition often involves episodes of psychosis, which include hallucinations, delusions, and disorganised thinking. Schizophrenia can significantly impair daily functioning, relationships, and quality of life.

Aetiology

The exact cause of schizophrenia is not fully understood, but it is believed to result from a complex interplay of genetic, biological, and environmental factors:

• Genetic Factors: Schizophrenia has a strong genetic component, with a higher risk among individuals who have a first-degree relative with the disorder.
• Neurobiological Factors: Abnormalities in brain structure and function, including neurotransmitter dysregulation (especially dopamine), are implicated in schizophrenia. Imaging studies often show changes in the brain's anatomy, such as enlarged ventricles.
• Environmental Factors: Prenatal exposure to infections, malnutrition, or stress, as well as complications during birth, can increase the risk of developing schizophrenia.
• Psychosocial Factors: Childhood trauma, social adversity, and substance abuse, particularly cannabis use during adolescence, may contribute to the onset of schizophrenia in individuals who are genetically predisposed.

Risk Factors

Several factors increase the likelihood of developing schizophrenia:

• Family History: Having a close relative with schizophrenia significantly increases the risk.
• Genetic Mutations: Specific genetic mutations and chromosomal abnormalities have been linked to an increased risk of schizophrenia.
• Neurodevelopmental Issues: Complications during pregnancy or birth, such as low birth weight or prematurity, can increase the risk.
• Substance Abuse: Early use of psychoactive substances, particularly cannabis, is associated with a higher risk of developing schizophrenia, especially in genetically vulnerable individuals.
• Stressful Life Events: Significant stress or trauma, particularly during childhood or adolescence, can contribute to the onset of schizophrenia in susceptible individuals.
• Urban Environment: Growing up or living in urban areas has been associated with an increased risk, possibly due to social stressors or environmental factors.

Clinical Presentation

Schizophrenia presents with a range of symptoms that are typically grouped into three categories: positive symptoms, negative symptoms, and cognitive symptoms:

Positive Symptoms

• Hallucinations: Sensory experiences that occur without an external stimulus, most commonly auditory hallucinations (hearing voices).
• Delusions: Strongly held false beliefs that are resistant to reason or contrary evidence. Common delusions include persecutory beliefs (e.g., feeling targeted or harassed) and grandiose beliefs (e.g., having exceptional abilities or importance).
• Disorganised Thinking: Incoherent or tangential speech, difficulty organising thoughts, and unpredictable or illogical thinking.
• Disorganised or Catatonic Behaviour: Unpredictable agitation, inappropriate behaviour, or catatonia (a state of unresponsiveness or motor immobility).

Negative Symptoms

• Affective Flattening: Reduced emotional expression, including facial expression, voice tone, and body language.
• Alogia: Poverty of speech or reduced speech output, leading to brief or empty replies.
• Anhedonia: Inability to experience pleasure or interest in previously enjoyable activities.
• Avolition: Lack of motivation to initiate or persist in goal-directed activities, leading to neglect of personal hygiene or other daily tasks.
• Social Withdrawal: Withdrawal from social interactions and a preference for solitude.

Cognitive Symptoms

• Impaired Attention: Difficulty focusing, sustaining attention, and filtering out distractions.
• Memory Problems: Impairments in working memory, which affect the ability to hold and manipulate information over short periods.
• Executive Dysfunction: Difficulty with planning, organising, and decision-making.

Investigations

The diagnosis of schizophrenia is primarily clinical, based on a detailed history, observation, and assessment of symptoms. Additional investigations may include:

• Psychiatric Assessment: A comprehensive mental health evaluation using structured interviews and diagnostic tools such as the Positive and Negative Syndrome Scale (PANSS) to assess the severity of symptoms.
• Medical History and Physical Examination: To rule out other medical conditions that could mimic or contribute to psychotic symptoms, such as neurological disorders or substance abuse.
• Laboratory Tests: Blood tests to exclude medical conditions such as thyroid dysfunction, infections, or substance use that may present with similar symptoms.
• Neuroimaging: Brain imaging, such as MRI or CT scans, may be used to rule out structural abnormalities or lesions in the brain that could cause psychotic symptoms.
• Electroencephalogram (EEG): To rule out seizure disorders or other neurological conditions that could contribute to psychosis.

Management

The management of schizophrenia involves a combination of pharmacological treatment, psychological therapies, and social support, tailored to the individual’s needs:

Pharmacotherapy

• Antipsychotic Medications: The cornerstone of schizophrenia treatment, antipsychotics help reduce the severity of psychotic symptoms. First-generation antipsychotics (e.g., haloperidol) and second-generation antipsychotics (e.g., risperidone, olanzapine) are commonly used. Second-generation antipsychotics tend to have fewer extrapyramidal side effects.
• Clozapine: An atypical antipsychotic reserved for treatment-resistant schizophrenia, where patients have not responded to other antipsychotic medications.
• Adherence to Medication: Regular follow-up to monitor adherence, manage side effects, and adjust dosages as necessary.

Psychological Therapies

• Cognitive Behavioural Therapy (CBT): Helps individuals manage symptoms, challenge delusional beliefs, and develop coping strategies to reduce distress.
• Family Therapy: Involves the family in the treatment process, providing education and support to help manage the condition and reduce relapse rates.
• Social Skills Training: Focuses on improving social interactions, communication skills, and daily functioning.
• Psychosocial Rehabilitation: Supports individuals in regaining social, occupational, and independent living skills to enhance quality of life.

Social Support

• Case Management: A case manager or community mental health worker can provide ongoing support, helping to coordinate care, manage crises, and connect individuals with social services.
• Supported Employment: Assistance with finding and maintaining employment, tailored to the individual’s abilities and needs.
• Housing Support: Access to supported housing or residential care, especially for individuals who struggle with independent living.
• Peer Support Groups: Participation in peer-led support groups can provide a sense of community and reduce feelings of isolation.

When to Refer

Referral to a specialist mental health service or psychiatrist is necessary in the following situations:

• First episode of psychosis or suspected schizophrenia requiring comprehensive assessment and initiation of treatment.
• Severe or treatment-resistant schizophrenia that does not respond to standard therapies, requiring specialised interventions such as clozapine.
• Presence of co-occurring mental health conditions, such as severe depression, anxiety, or substance abuse.
• Significant impairment in daily functioning, including difficulties in self-care, social interactions, or occupational performance.
• Need for specialised psychological therapies, such as CBT for psychosis, that are not available in primary care settings.
• Risk of harm to self or others, necessitating urgent intervention and possible hospitalisation.

References

1. NHS (2024) Schizophrenia. Available at: https://www.nhs.uk/conditions/schizophrenia/ (Accessed: 26 August 2024).
2. National Institute for Health and Care Excellence (2024) Psychosis and Schizophrenia in Adults: Prevention and Management. Available at: https://www.nice.org.uk/guidance/cg178 (Accessed: 26 August 2024).
3. British Medical Journal (2024) Schizophrenia: Clinical Review. Available at: https://www.bmj.com/content/350/bmj.h682 (Accessed: 26 August 2024).

Back to Top